$AIP

Bayview Legacy, LLC sold $4.5M of AIP (indirect holdings)

Bayview Legacy, LLC sold 125,976 indirectly-held shares of Arteris, Inc. (AIP) at an average of $35.79 ($35.06–$37.07, $4.51M total) across 3 trades on 2026-07-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Bayview Legacy, LLC
Published Jul 8, 2026, 8:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 8, 2026, 8:21 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$AIP
Neutral
medium confidence
Mentioned
$AIP
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPNeutralLow
01

Why it matters

The newest concrete fact is the disclosed sale size ($4.51M) and the trade window (2026-07-06) at $35.0650 to $37.0705 per share under a 10b5-1 plan.

02

Market read

A disclosed 10b5-1 sale can slightly pressure sentiment, but it is typically not a standalone fundamental catalyst.

03

What to watch

Traders should check whether there are additional Form 4 filings around the same period or changes in total beneficial ownership across related entities, which could matter more than a single sale.

Relevance 5/10Novelty 3/10Timing: after-hours filing on 2026-07-08 for trades dated 2026-07-06

Background

The article is an SEC Form 4 insider transaction disclosure for Arteris, Inc. (AIP), reported by Bayview Legacy, LLC as a 10% owner with indirect holdings.

Company-level read

Ticker impact

$AIPNeutralMedium confidence
Context

Bayview Legacy, LLC (10% owner) filed a Form 4 showing an indirect open-market sale of 125,976 AIP shares on 2026-07-06.

Expected impact

Likely limited, short-lived impact unless follow-on filings show accelerated selling or plan changes.

Evidence & confidence

The filing is a routine 10b5-1 open-market sale with a defined trade date and weighted-average price range, and it does not include new operating or financial guidance.

Market effects

No sector-level implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect liquidity management rather than bearish expectations.

Key entities

  • Arteris, Inc.

    Subject of the Form 4 insider transaction disclosure (AIP).

  • Bayview Legacy, LLC

    10% owner reporting an indirect open-market sale under a 10b5-1 plan.

Related articles

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991q2fy268-k.htm EX-99.1 Document Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor techn